A precision medicine approach to metabolic therapy for breast cancer in mice

Increasing evidence highlights approaches targeting metabolism as potential adjuvants to cancer therapy. Sodium-glucose transport protein 2 (SGLT2) inhibitors are the newest class of antihyperglycemic drugs. To our knowledge, SGLT2 inhibitors have not been applied in the neoadjuvant setting as a pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Akingbesote, Ngozi D., Norman, Aaron, Zhu, Wanling, Halberstam, Alexandra A., Zhang, Xinyi, Foldi, Julia, Lustberg, Maryam B., Perry, Rachel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122928/
https://www.ncbi.nlm.nih.gov/pubmed/35595952
http://dx.doi.org/10.1038/s42003-022-03422-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122928/
https://www.ncbi.nlm.nih.gov/pubmed/35595952
http://dx.doi.org/10.1038/s42003-022-03422-9

Ejemplares similares